Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study

OBJECTIVE: Hydroxychloroquine has been proposed as a primary prophylactic agent against coronavirus disease 2019 (COVID-19). This study aimed to investigate if patients treated with hydroxychloroquine for a non-COVID-19 indication had a lower risk of verified infection with severe acute respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamstrup, Peter, Sivapalan, Pradeesh, Eklöf, Josefin, Hoyer, Nils, Ulrik, Charlotte Suppli, Pedersen, Lars, Lapperre, Therese S., Harboe, Zitta Barrella, Bodtger, Uffe, Bojesen, Rasmus Dahlin, Håkansson, Kjell E.J., Tidemandsen, Casper, Armbruster, Karin, Browatzki, Andrea, Meteran, Howraman, Meyer, Christian Niels, Skaarup, Kristoffer Grundtvig, Lassen, Mats Christian Højbjerg, Lundgren, Jens D., Biering-Sørensen, Tor, Jensen, Jens-Ulrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168303/
https://www.ncbi.nlm.nih.gov/pubmed/34087484
http://dx.doi.org/10.1016/j.ijid.2021.05.076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168303/
https://www.ncbi.nlm.nih.gov/pubmed/34087484
http://dx.doi.org/10.1016/j.ijid.2021.05.076

Ejemplares similares